Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer. - Wikidata - wikimedia - TriplyDB

Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

http://www.wikidata.org/entity/Q35118166

about

Contribution of CXCL12 secretion to invasion of breast cancer cells.Opposing roles of CXCR4 and CXCR7 in breast cancer metastasis.Putative biomarkers and targets of estrogen receptor negative human breast cancer The wound healing, chronic fibrosis, and cancer progression triad CXCL13-CXCR5 co-expression regulates epithelial to mesenchymal transition of breast cancer cells during lymph node metastasis Synergistic antitumor effects of endostar in combination with oxaliplatin via inhibition of HIF and CXCR4 in the colorectal cell line SW1116 Ectopic microRNA-150-5p transcription sensitizes glucocorticoid therapy response in MM1S multiple myeloma cells but fails to overcome hormone therapy resistance in MM1R cells CXCR4 drives the metastatic phenotype in breast cancer through induction of CXCR2 and activation of MEK and PI3K pathways Adenosine arrests breast cancer cell motility by A3 receptor stimulation.Extracts from Curcuma zedoaria Inhibit Proliferation of Human Breast Cancer Cell MDA-MB-231 In Vitro.Blood vessel endothelium-directed tumor cell streaming in breast tumors requires the HGF/C-Met signaling pathway.Effect of biodegradability on CXCR4 antagonism, transfection efficacy and antimetastatic activity of polymeric Plerixafor GPCRs and cancer The role of chemokines in breast cancer pathology and its possible use as therapeutic targets The CXCR4 antagonist AMD3465 regulates oncogenic signaling and invasiveness in vitro and prevents breast cancer growth and metastasis in vivo Endocrine disrupting chemicals promote the growth of ovarian cancer cells via the ER-CXCL12-CXCR4 signaling axis.Silencing MED1 sensitizes breast cancer cells to pure anti-estrogen fulvestrant in vitro and in vivo.MEK5/ERK5 signaling suppresses estrogen receptor expression and promotes hormone-independent tumorigenesis Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor-positive breast cancers.The intricate role of CXCR4 in cancer.Examination of structure-activity relationship of viologen-based dendrimers as CXCR4 antagonists and gene carriers.Translational horizons in the tumor microenvironment: harnessing breakthroughs and targeting cures.Three interrelated themes in current breast cancer research: gene addiction, phenotypic plasticity, and cancer stem cells.Role of estrogen receptor signaling in breast cancer metastasis.Emerging candidates in breast cancer stem cell maintenance, therapy resistance and relapse.PAX2 is activated by estradiol in breast cancer cells of the luminal subgroup selectively, to confer a low invasive phenotype.Effects of SDF-1-CXCR4 signaling on microRNA expression and tumorigenesis in estrogen receptor-alpha (ER-α)-positive breast cancer cells.Meta-Analysis of Tumor Stem-Like Breast Cancer Cells Using Gene Set and Network Analysis.Laser Direct-Write Onto Live Tissues: A Novel Model for Studying Cancer Cell Migration.G Protein Coupled Receptor Kinase 3 Regulates Breast Cancer Migration, Invasion, and Metastasis.CXCR4 activation maintains a stem cell population in tamoxifen-resistant breast cancer cells through AhR signalling Pharmacology and anti-tumor activity of RWJ67657, a novel inhibitor of p38 mitogen activated protein kinase Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways?Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer A novel autologous cell-based therapy to promote diabetic wound healing.Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation.Expression of osteoprotegerin, receptor activator of nuclear factor kappa-B ligand, tumor necrosis factor-related apoptosis-inducing ligand, stromal cell-derived factor-1 and their receptors in epithelial metastatic breast cancer cell lines.Clinical Trial of Acolbifene in Premenopausal Women at High Risk for Breast Cancer.Microenvironment and endocrine resistance in breast cancer: Friend or foe?GLI1 orchestrates CXCR4/CXCR7 signaling to enhance migration and metastasis of breast cancer cells.

P2860

Q22000754-330FB6A2-5341-4009-A67D-CAF1D66B1344 Q22000756-D1E7C814-BE95-4F4F-95F6-E23E43EB7936 Q27003285-D6EF7308-06B9-4938-8C81-8264B8B955D1 Q27014616-2E572776-396D-4847-AA66-5E5CEDFA2709 Q28304012-9ED487DB-7296-4E68-ADCD-0342E4DC9397 Q28484315-52C23B70-8522-4291-BE2E-07952BDC2EA2 Q28542491-46A807EC-8141-41F4-B20D-3EDACD9B790E Q30572945-BE27B51E-3E46-4E8E-93B2-853FF868E652 Q30829844-AD6C69ED-D8E9-4A68-B782-5B34678A4F55 Q33634352-A221A39B-C915-4759-8435-27ABA41C71D8 Q33665092-3170941F-0298-478F-AF71-A030360C2198 Q33687703-5EAEB5B0-A367-4E9F-AF52-37330DB1C6B0 Q33828719-30B6042A-D4F1-49E9-ACA0-C76761292D1E Q34069862-98299251-D122-4E77-859F-A64B7BD65CB7 Q34618835-96B644EE-4CEF-4B2D-9432-DF41C54F20E2 Q34881148-E53067C0-636D-4427-A10C-B28FA8C1D0A7 Q34923304-1E776D26-D953-4537-8869-86F8C4D5FFFE Q34946215-14BBCED8-C173-4924-A11C-800EF42BA303 Q35000307-EFBE240A-0742-4A94-85B8-331779A23F35 Q35067624-DE73FCAF-35A0-4933-A49F-FC1F3F79CC7C Q35167546-199D1DE0-DF08-4EF5-9B9C-F529E3CB8B86 Q35219539-2E3B2AF2-CBC2-4EB0-B5AA-57B7ABA1B1D2 Q35683502-5F3BF96F-45E6-4C6C-8A79-2ABEB9388D00 Q35684545-2231F033-6D18-4773-A129-7DC2B7BD7A7D Q35686250-E4EDA06C-F070-4F96-9582-BA3373F3126A Q35690099-41D16D11-F448-49E2-B663-1A05EF408298 Q35906736-F5528033-3591-42FB-813B-72EF8C79F326 Q35921899-5774950E-1F41-4AC8-AF3C-EF41B620376E Q35938703-537C2F3C-15F7-4B5F-BE8B-A033C2D1A87C Q35980816-865837E2-346E-4A07-8F9E-FED00F36791F Q36075168-478D6634-D12D-4555-9FE6-28632ADF71FE Q36135818-0CF07E7C-5123-4783-BE33-A731DBD0C203 Q36175119-0F8E4410-32BA-48AD-B202-969AA8C97E83 Q36280164-F11C5CEB-870E-486C-975E-AE174CF283CF Q36301623-EF5DB085-ECAA-497B-ACE9-95EDBBA164A0 Q36316580-1F4D022A-5190-4A07-A427-554A91222AE4 Q36338510-988F7057-53BC-4336-A51D-4462E6C0844F Q36349610-AF109CEF-390E-40A2-A8C9-17D555001852 Q36363626-493BE0B4-8C26-4893-802D-28283E4DBE38 Q36545242-49C7D2D8-F874-4D54-805C-85F186B22DEA

P2860

Cytokine receptor CXCR4 mediates estrogen-independent tumorigenesis, metastasis, and resistance to endocrine therapy in human breast cancer.

http://www.wikidata.org/entity/Q35118166

description

2010 nî lūn-bûn

@nan

2010 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի դեկտեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Cytokine receptor CXCR4 mediat ...... herapy in human breast cancer.

@ast

Cytokine receptor CXCR4 mediat ...... herapy in human breast cancer.

@en

type

label

Cytokine receptor CXCR4 mediat ...... herapy in human breast cancer.

@ast

Cytokine receptor CXCR4 mediat ...... herapy in human breast cancer.

@en

prefLabel

Cytokine receptor CXCR4 mediat ...... herapy in human breast cancer.

@ast

Cytokine receptor CXCR4 mediat ...... herapy in human breast cancer.

@en

P1433

Q35118166-195DC173-4927-40F9-BE0C-7916D5AFB552

P1476

Q35118166-238E280C-36A5-420B-BF3B-42A40E72CE5E

P2093

Q35118166-01FF510F-BEFB-4EAF-A88D-B661DBB0374C

Q35118166-02B3240A-27E3-4445-AE96-B63FA02ECDF4

Q35118166-03C86EFE-EC74-4A15-8789-7402E8B71ACD

Q35118166-0A753070-0267-4D4F-87FE-09E4FDD47048

Q35118166-1A8DE476-A004-46A7-BABB-EC9DABD13B46

Q35118166-24A26B27-8D07-489C-BA7C-AD6F44737C2A

Q35118166-2AC04616-8803-40AB-8D53-E28F58A14E80

Q35118166-3A40FB19-521D-4CD4-BE63-88C2C20AAC2D

Q35118166-3B3A6A80-EB09-4E60-A96A-E9E4EF050786

Q35118166-43B2FEB0-E069-40A0-AB2C-EA1FA4B5F302

P2860

Q35118166-05B587A8-CAC7-4173-A834-844D332A97D2

Q35118166-05E3DF38-00F7-494E-92AD-43D11C4036AE

Q35118166-091B86F4-28B4-4B11-880D-34C70FBD69FA

Q35118166-0CA4A411-1DE0-45ED-BBEE-17F0093735CE

Q35118166-13EAA61A-CC72-47B5-833E-D02B5D6DBE65

Q35118166-19C5D7CA-FA19-4B14-BB71-AD0421BA1F6B

Q35118166-25471359-9BEB-4FA3-B8BA-A0BB9D4904B4

Q35118166-25E77706-AC0E-4709-86C2-BCBECAC6C1F6

Q35118166-29016C49-8A10-4BC9-A49A-9DDB28002642

Q35118166-29B63806-6CBF-4C8B-AE98-7FE81E48774A

P304

Q35118166-4000469A-EDA4-45AE-9AE5-98A771010D6A

P31

Q35118166-A4E623BB-E5EF-4798-80C6-6BACF6FC7B05

P356

Q35118166-33CC29E9-647D-4CA9-B466-48F927876847

P407

Q35118166-EB72D87D-31A2-4CAB-A47E-2E4C5B6E1BBF

P433

Q35118166-8149E09D-B880-449D-92B7-F4E9C5073E8E

P478

Q35118166-0BCE5806-EE23-4051-B468-F751D264778B

P50

Q35118166-7C99963F-3AAC-4302-AD71-F18FF67EAD6F

Q35118166-DA3C7AA6-5204-4FFC-95F7-47EC62F2AFE5

P577

Q35118166-4E3D0B3C-5A95-4EE7-82DC-19FBB6CD784C

P5875

Q35118166-0F583C20-1009-449D-973E-B46EE7006EF2

P698

Q35118166-49CF31FE-73C2-4812-923D-9B53B9B6A187

P932

Q35118166-B814B6DB-C786-45FA-A327-A1369106A7A8

P356

0008-5472.CAN-10-3185

P1433

Cancer Research

P1476

Cytokine receptor CXCR4 mediat ...... herapy in human breast cancer.

@en

P2093

Ann Richmond

http://www.w3.org/2001/XMLSchema#string

Barbara S Beckman

http://www.w3.org/2001/XMLSchema#string

Bridgette M Collins-Burow

http://www.w3.org/2001/XMLSchema#string

Charles E Wood

http://www.w3.org/2001/XMLSchema#string

Chris Segar

http://www.w3.org/2001/XMLSchema#string

Dihua Yu

http://www.w3.org/2001/XMLSchema#string

Juan P Fonseca

http://www.w3.org/2001/XMLSchema#string

Kenneth P Nephew

http://www.w3.org/2001/XMLSchema#string

Linda W Horton

http://www.w3.org/2001/XMLSchema#string

Matthew E Burow

http://www.w3.org/2001/XMLSchema#string

P2860

Involvement of chemokine receptors in breast cancer metastasis

Regulation of cell-cell adhesion by the cadherin-catenin complex

Glyceollin I, a novel antiestrogenic phytoalexin isolated from activated soy

Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma

Phosphatidylinositol 3-kinase/AKT-mediated activation of estrogen receptor alpha: a new model for anti-estrogen resistance

CXCR4 regulates growth of both primary and metastatic breast cancer

Relevance of breast cancer antiestrogen resistance genes in human breast cancer progression and tamoxifen resistance

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

Molecular effects of soy phytoalexin glyceollins in human prostate cancer cells LNCaP.

P304

603-613

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/0008-5472.CAN-10-3185

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

71

http://www.w3.org/2001/XMLSchema#string

P50

P577

2010-12-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

49650661

http://www.w3.org/2001/XMLSchema#string

P698

21123450

http://www.w3.org/2001/XMLSchema#string

P932

3140407

http://www.w3.org/2001/XMLSchema#string